iBio Inc. (IBIO)
NASDAQ: IBIO
· Real-Time Price · USD
0.86
-0.01 (-1.60%)
At close: Jun 17, 2025, 10:29 AM
-1.60% (1D)
| Bid | 0.62 |
| Market Cap | 14.13M |
| Revenue (ttm) | 375K |
| Net Income (ttm) | -20.99M |
| EPS (ttm) | -0.04 |
| PE Ratio (ttm) | -21.38 |
| Forward PE | -0.67 |
| Analyst | Buy |
| Ask | 1.07 |
| Volume | 107,767 |
| Avg. Volume (20D) | 1,107,512 |
| Open | 0.88 |
| Previous Close | 0.87 |
| Day's Range | 0.81 - 0.89 |
| 52-Week Range | 0.64 - 6.89 |
| Beta | 0.94 |
About IBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IBIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
1 year ago · proactiveinvestors.com
iBio partners with AstralBio to develop obesity treatments using AI-driven platformiBio, an AI-driven drug developer, shares surged more than 120% after it announced it has entered into a collaboration agreement with private biotech firm AstralBio to discover, engineer and develop n...
